Response to ‘Eruptive keratoacanthomas associated with dupilumab therapy’

Case of a patient developing multiple rashes of squamous cell carcinoma 6 weeks after the introduction of dupilumab due to atopic eczema.[Image: see text]

Detalles Bibliográficos
Autores principales: Patchinsky, Alexandra, Kalita, Victoria, Muller, Philippe, Petitpain, Nadine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10233080/
https://www.ncbi.nlm.nih.gov/pubmed/37275419
http://dx.doi.org/10.1002/ski2.197
_version_ 1785052154798538752
author Patchinsky, Alexandra
Kalita, Victoria
Muller, Philippe
Petitpain, Nadine
author_facet Patchinsky, Alexandra
Kalita, Victoria
Muller, Philippe
Petitpain, Nadine
author_sort Patchinsky, Alexandra
collection PubMed
description Case of a patient developing multiple rashes of squamous cell carcinoma 6 weeks after the introduction of dupilumab due to atopic eczema.[Image: see text]
format Online
Article
Text
id pubmed-10233080
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-102330802023-06-02 Response to ‘Eruptive keratoacanthomas associated with dupilumab therapy’ Patchinsky, Alexandra Kalita, Victoria Muller, Philippe Petitpain, Nadine Skin Health Dis Letters to the Editor Case of a patient developing multiple rashes of squamous cell carcinoma 6 weeks after the introduction of dupilumab due to atopic eczema.[Image: see text] John Wiley and Sons Inc. 2023-03-02 /pmc/articles/PMC10233080/ /pubmed/37275419 http://dx.doi.org/10.1002/ski2.197 Text en © 2022 The Authors. Skin Health and Disease published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letters to the Editor
Patchinsky, Alexandra
Kalita, Victoria
Muller, Philippe
Petitpain, Nadine
Response to ‘Eruptive keratoacanthomas associated with dupilumab therapy’
title Response to ‘Eruptive keratoacanthomas associated with dupilumab therapy’
title_full Response to ‘Eruptive keratoacanthomas associated with dupilumab therapy’
title_fullStr Response to ‘Eruptive keratoacanthomas associated with dupilumab therapy’
title_full_unstemmed Response to ‘Eruptive keratoacanthomas associated with dupilumab therapy’
title_short Response to ‘Eruptive keratoacanthomas associated with dupilumab therapy’
title_sort response to ‘eruptive keratoacanthomas associated with dupilumab therapy’
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10233080/
https://www.ncbi.nlm.nih.gov/pubmed/37275419
http://dx.doi.org/10.1002/ski2.197
work_keys_str_mv AT patchinskyalexandra responsetoeruptivekeratoacanthomasassociatedwithdupilumabtherapy
AT kalitavictoria responsetoeruptivekeratoacanthomasassociatedwithdupilumabtherapy
AT mullerphilippe responsetoeruptivekeratoacanthomasassociatedwithdupilumabtherapy
AT petitpainnadine responsetoeruptivekeratoacanthomasassociatedwithdupilumabtherapy

Ejemplares similares